Jill Sakai, Author at The Rheumatologist

Articles by Jill Sakai

ACR Advocacy: 2019 Year in Review

Blair Solow, MD | January 5, 2020

As a new year begins, Government Affairs Committee chair Blair Solow, MD, takes stock of ACR advocacy wins in 2019 and issues to watch in 2020.

ACR Leverages AMA Representation to Advance Rheumatology Issues

Adam Cooper | November 21, 2019

The ACR’s delegation to the AMA HOD meeting in November successfully advanced resolutions to advocate for pharmacy benefit manager transparency and expanded patient protections from step therapy protocols.

A Farewell Message from Outgoing Government Affairs Committee Chair Angus Worthing, MD, FACR, FACP

Angus Worthing, MD, FACP, FACR | November 7, 2019

A farewell message from outgoing Government Affairs Committee Chair Angus Worthing urges ACR/ARP members to advocate for the rheumatology profession.

Using RISE Data in Research

Elizabeth Hofheinz, MPH, MEd | October 17, 2019

The ACR’s RISE registry offers answers on real-world experience to researchers.

Drug Pricing Bills Move Forward

Angus Worthing, MD, FACP, FACR | September 20, 2019

This week, the U.S. House of Representatives released a long-anticipated plan that contains provisions to reduce U.S. drug prices according to an international price index.

RheumPAC Advocates for Department of Defense Arthritis Research Funding

Matt Baker, MD, MS | August 1, 2019

The ACR’s nonpartisan political action committee is continuing to advocate for increased defense department funding for rheumatology research. Learn about RheumPAC’s efforts and how you can help.